TMCnet News
Spineology® Secures $5 Million Investment from Hermed CapitalSpineology Inc., the innovator in anatomy-conserving surgery™, is pleased to announce that Hermed Capital, a private equity fund located in Shanghai, China, has made a $5 million investment in the form of a convertible debenture. The proceeds from this financing are expected to fund additional commercialization, product development, and clinical research efforts for the company. "We believe the Spineology investment is a very exciting opportunity," stated Dr. Jerry Xiao, Managing Director of Hermed Capital. "Spineology possesses a very novel product portfolio in an otherwise very homogeneous market. We look forward to working with them as they grow in the U.S. and hope to be able to leverage our resources as they begin to explore global opportunities." "The Hermed investment comes at a very opportune time for Spineology," said John Booth, CE for Spineology. "With the recent approvals of Rampart One and Duo we are poised to dramatically expand our procedure base into additional market segments." The Duo System significantly reduces the surgical access required for lateral procedures while providing a large conforming device footprint. The Rampart One System minimizes the exposure requirements associated with anterior spinal fusion procedures and is manufactured from Invibio® PEEK-OPTIMA® HA Enhanced material.
About Spineology Inc.
About Hermed Capital Co. Ltd.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170913006149/en/ |